WHY NORTHBUD FARMS?
- Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
As shown in other legal jurisdictions (Colorado, Washington, Nevada, California) - Infused products sector has become the highest margin segment of the industry
- Positioned to be a raw input producer for this space
- Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
RECENT HIGHLIGHTS
North Bud Farms Signs Binding Letter of Intent to Acquire Nevada Botanical Science
- Transaction valued at USD$7 million
- Medical and adult use licenses for cultivation extraction and distribution.
- NBS currently operates a 5,000 sq. ft. indoor cultivation facility and have been approved for expansion of up to 100,000 sq. ft.
- Located in Reno, Nevada
North Bud Farms Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor
- Transaction valued at CAD$20 million
- In 2018, Eureka recognized revenue of approximately CAD$11.5 million*
- net profit margin of 16%* from its California and Colorado operations
- Anticipates further growth in revenue due to anticipated changes to retail regulation of adult cannabis use in California.
Justin Braune, CEO of Eureka Vapor, joins Scott to share the company’s background and why Eureka was an ideal match for North Bud. Watch until the end to hear Justin’s predictions on Federal de-regulation in the US.
FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.
Tags: Cannabis, CBD, CSE, Hemp, infused cannabis, Marijuana, stocks, tsx, tsx-v, weed